Search Results 101-110 of 21510 for lupus
Starting from the beginning may lead to better outcomes for lupus featured image. Health & Wellness. Starting from the beginning may lead to better outcomes ...
This observational study is a registry designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the ...
Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on skin exposed to ...
Systemic autoimmune diseases — systemic lupus erythematosus, scleroderma, myositis and related disorders. Inflammatory arthritis — rheumatoid arthritis ...
Infections · Post-streptococcal glomerulonephritis. ; Autoimmune diseases · Lupus. ; Vasculitis · Polyarteritis. ; Sclerotic conditions · High blood pressure. ; Other ...
Systemic lupus erythematosus (SLE) · Autoimmune toxicities of cancer immunotherapies (i.e. immune-related adverse events) ...
A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/or Subacute Cutaneous Lupus Erythematosus (LAVENDER).
In other findings, Mayo discovered a clue to why lupus tends to be worse in African-Americans; chronicled erratic blood pressure in rheumatoid arthritis ...
Having another autoimmune condition, such as systemic lupus erythematosus or other connective tissue diseases, increases the risk of antiphospholipid syndrome.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.